Review
CC-5013 (Celgene)
Affiliations
- PMID: 15242253
Item in Clipboard
Review
CC-5013 (Celgene)
Curr Opin Investig Drugs.
2004 Jun.
Abstract
Celgene, in collaboration with the National Cancer Institute, is developing CC-5013, the lead compound in a series of thalidomide derivatives that inhibit TNFalpha overproduction, for the potential treatment of hematological and solid tumor cancers and inflammatory diseases.
Similar articles
-
Thalidomide as a novel therapeutic agent: new uses for an old product.Drug Discov Today. 2005 Jan 15;10(2):107-14. doi: 10.1016/S1359-6446(04)03307-0. Drug Discov Today. 2005. PMID: 15718159 Review.
-
BMS-247550 Bristol-Myers Squibb/GBF.Curr Opin Investig Drugs. 2003 Jun;4(6):746-56. Curr Opin Investig Drugs. 2003. PMID: 12901236 Review.
-
Epothilone D (Kosan/Roche).Curr Opin Investig Drugs. 2004 Jun;5(6):657-67. Curr Opin Investig Drugs. 2004. PMID: 15242255 Review.
-
OSI-461 (OSI).Curr Opin Investig Drugs. 2004 Jun;5(6):648-56. Curr Opin Investig Drugs. 2004. PMID: 15242254 Review.
-
BAY-43-9006 Bayer/Onyx.Curr Opin Investig Drugs. 2003 Jun;4(6):757-63. Curr Opin Investig Drugs. 2003. PMID: 12901237 Review.
Cited by
-
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies.J Blood Med. 2010;1:1-8. doi: 10.2147/JBM.S7284. Epub 2010 Feb 25. J Blood Med. 2010. PMID: 22282677 Free PMC article.
-
Targeting angiogenesis for the treatment of prostate cancer.Expert Opin Ther Targets. 2012 Apr;16(4):365-76. doi: 10.1517/14728222.2012.668887. Epub 2012 Mar 13. Expert Opin Ther Targets. 2012. PMID: 22413953 Free PMC article. Review.
-
Development and validation of Lenalidomide in human plasma by LC-MS/MS.Saudi J Biol Sci. 2019 Nov;26(7):1843-1847. doi: 10.1016/j.sjbs.2018.02.006. Epub 2018 Feb 13. Saudi J Biol Sci. 2019. PMID: 31762666 Free PMC article.
-
Lenalidomide alone and in combination for chronic lymphocytic leukemia.Curr Hematol Malig Rep. 2013 Mar;8(1):7-13. doi: 10.1007/s11899-012-0146-x. Curr Hematol Malig Rep. 2013. PMID: 23254517 Review.
-
Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney).Bone Marrow Res. 2011;2011:493697. doi: 10.1155/2011/493697. Epub 2011 May 4. Bone Marrow Res. 2011. PMID: 22046563 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources